Celularity Inc. Diluted Shares Outstanding (Weighted Average)
Celularity Inc. (CELU) reported Diluted Shares Outstanding (Weighted Average) of 25.60 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-04-30
- Celularity Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 28.45M shares, a 27.64% increase year-over-year.
- Celularity Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 26.35M shares, a 19.89% increase year-over-year.
- Celularity Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 24.02M shares, a 9.93% increase year-over-year.
- Celularity Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 23.53M shares, a 9.75% increase year-over-year.
- Celularity Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 25.60M shares, a 16.94% increase from fiscal 2024.
- Celularity Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 21.89M shares, a 22.89% increase from fiscal 2023.
- Celularity Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 17.81M shares, a 18.89% increase from fiscal 2022.
- Celularity Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 14.98M shares, a 77.66% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 28.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | 27.40M shares derived: average of 2 quarters · filed 2026-04-30 | 26.27M shares derived: average of 3 quarters · filed 2026-04-30 | 25.60M shares 10-K · filed 2026-04-30 | ||||
| 2025-09-30 | 26.35M shares 10-Q · filed 2025-11-14 | 25.18M shares derived: average of 2 quarters · filed 2025-11-14 | 24.65M shares 10-Q · filed 2025-11-14 | 24.05M shares derived: average of 4 quarters · filed 2026-04-30 | ||||
| 2025-06-30 | 24.02M shares 10-Q · filed 2025-08-29 | 23.78M shares 10-Q · filed 2025-08-29 | 23.28M shares derived: average of 3 quarters · filed 2026-04-30 | 22.95M shares derived: average of 4 quarters · filed 2026-04-30 | ||||
| 2025-03-31 | 23.53M shares 10-Q · filed 2025-08-29 | 22.91M shares derived: average of 2 quarters · filed 2026-04-30 | 22.60M shares derived: average of 3 quarters · filed 2026-04-30 | 22.41M shares derived: average of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | 22.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | 22.13M shares derived: average of 2 quarters · filed 2026-04-30 | 22.04M shares derived: average of 3 quarters · filed 2026-04-30 | 21.89M shares 10-K · filed 2026-04-30 | ||||
| 2024-09-30 | 21.98M shares 10-Q · filed 2025-11-14 | 21.91M shares derived: average of 2 quarters · filed 2025-11-14 | 21.76M shares 10-Q · filed 2025-11-14 | 21.11M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 21.85M shares 10-Q · filed 2025-08-29 | 21.65M shares 10-Q · filed 2025-08-29 | 20.83M shares derived: average of 3 quarters · filed 2025-08-29 | 20.33M shares derived: average of 4 quarters · filed 2025-08-29 | ||||
| 2024-03-31 | 21.44M shares 10-Q · filed 2025-08-29 | 20.32M shares derived: average of 2 quarters · filed 2025-08-29 | 19.82M shares derived: average of 3 quarters · filed 2025-08-29 | 19.28M shares derived: average of 4 quarters · filed 2025-08-29 | ||||
| 2023-12-31 | 19.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | 19.01M shares derived: average of 2 quarters · filed 2025-05-08 | 18.56M shares derived: average of 3 quarters · filed 2025-05-08 | 17.81M shares 10-K · filed 2025-05-08 | ||||
| 2023-09-30 | 18.83M shares 10-Q · filed 2024-12-06 | 188.32M shares 10-Q · filed 2024-01-03 | 18.24M shares derived: average of 2 quarters · filed 2024-12-06 | 17.35M shares 10-Q · filed 2024-12-06 | 173.54M shares 10-Q · filed 2024-01-03 | -75.35M shares derived: average of 4 quarters · filed 2024-12-06 | ||
| 2023-06-30 | 17.66M shares 10-Q · filed 2024-11-07 | 176.56M shares 10-Q · filed 2023-08-14 | 16.60M shares 10-Q · filed 2024-11-07 | 166.02M shares 10-Q · filed 2023-08-14 | -106.75M shares derived: average of 3 quarters · filed 2024-11-07 | -42.42M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-03-31 | 15.54M shares 10-Q · filed 2024-10-16 | 155.37M shares 10-Q · filed 2023-05-22 | -168.95M shares derived: average of 2 quarters · filed 2024-10-16 | -62.45M shares derived: average of 3 quarters · filed 2024-10-16 | -9.01M shares derived: average of 4 quarters · filed 2024-10-16 | |||
| 2022-12-31 | -353.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -101.44M shares derived: average of 2 quarters · filed 2024-07-30 | -17.19M shares derived: average of 3 quarters · filed 2024-07-30 | 14.98M shares 10-K · filed 2024-07-30 | 149.83M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 150.55M shares 10-Q · filed 2024-01-03 | 150.93M shares derived: average of 2 quarters · filed 2024-01-03 | 137.79M shares 10-Q · filed 2024-01-03 | 139.07M shares derived: average of 4 quarters · filed 2024-01-03 | ||||
| 2022-06-30 | 151.31M shares 10-Q · filed 2023-08-14 | 135.30M shares 10-Q · filed 2023-08-14 | 135.24M shares derived: average of 3 quarters · filed 2023-08-14 | 132.33M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 130.40M shares 10-Q · filed 2023-05-22 | 127.21M shares derived: average of 2 quarters · filed 2023-05-22 | 126.00M shares derived: average of 3 quarters · filed 2023-05-22 | 100.50M shares derived: average of 4 quarters · filed 2023-05-22 | ||||
| 2021-12-31 | 124.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 123.80M shares derived: average of 2 quarters · filed 2023-03-31 | 90.53M shares derived: average of 3 quarters · filed 2023-03-31 | 67.06M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 123.58M shares 10-Q · filed 2022-11-10 | 73.79M shares derived: average of 2 quarters · filed 2022-11-10 | 48.07M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 23.99M shares 10-Q · filed 2022-08-09 | 23.99M shares 10-Q · filed 2022-08-09 | ||||||
| 2020-09-30 | 18.42M shares 10-Q · filed 2021-11-12 | 18.41M shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |